T-cell therapy shows promise in treating aggressive cancer

An emerging treatment that modifies an individual’s own T cells may be effective for slowing or even reversing the progression of glioblastoma, a highly aggressive and fatal brain cancer, a clinical trial co-led by Yale immunobiologist Lieping Chen found.